THQ News and Press, Tekla Healthcare Opportunies Fund Shares of Beneficial Interest From 02/02/23

Summary Do you love snagging things on sale? I know my wife does! Often in the market, investors eschew great opportunities simply because other investors have put them on sale. You can preserve capital, and grow it by buying on sale income. Co-produced with Treading Sof...

Summary Gossamer's TORREY showed stat sig PVR improvement, but the 6MWD was under what investors were hoping for; this led to a +70% decline in share price. Seralutnib is entering phase 3 with an adapted design (with more severe patients); although the success is less clear, any positiv...

Summary For income investors, closed-end funds remain an attractive investment class that covers a variety of asset classes and promises high distributions and reasonable total returns. Closed-end funds are generally characterized by higher volatility and deeper drawdowns than the broad...

Summary Tekla World Healthcare Fund is a healthcare-focused closed-end fund with $500 million in net assets. It pays a 9.2% market yield, or 10.6% of NAV yield. While there's no imminent risk to the distribution rate, there is a long-term gap between the fund's average annual total ...

Summary THQ is a CEF focused on the defensive healthcare sector. The fund pays a healthy 6.8% current yield. Although THQ underperforms a sector ETF like the XLV, for investors who are more interested in current yield, THQ could be a good bet. The Tekla Healthcare Opportun...

Summary Cash assets may provide psychological comfort but are sure to result in defeat vs. long-term inflation. Periodic selling of portfolio positions is not a sustainable retirement strategy. Invest in productive assets that keep you wealthy through good and bad times. Two pic...

Summary We share data on over 50 big-yield healthcare investments, including individual stocks, REITs, closed-end funds ("CEFs") and bonds. We dive deeper into three specific attractive big-yield opportunities that also have healthy upside potential. We begin with a special focus on...

Summary October had the broader indexes rebounding after their lackluster September. With limited cash to put to work this month after an aggressive September, I was more conservative in buying. I added to positions that I already held, with two positions being names I bought ...

Summary Healthcare industry, especially the large-cap pharmaceutical, biotechnology, and managed healthcare stocks are doing well and outperforming the market. More stocks in THQ’s top 70 percent equity portfolio generated high positive price growth than the number of stock...

Summary THW is still continuing with a steady monthly payout and generating close to double-digit yield, and it is relatively better protected from market risk. THW failed to grow during the past six months, as its major holdings failed to generate price growth. However, total ret...